Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers.
Saved in:
| Title: | Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers. |
|---|---|
| Authors: | Busch E; Department of Medical Oncology, National Centre for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Ahadova A; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Kosmalla K; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Bohaumilitzky L; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Pfuderer PL; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Ballhausen A; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Witt J; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Wittemann JN; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Bläker H; Institute of Pathology, University Hospital Leipzig, Leipzig, Germany., Holinski-Feder E; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.; MGZ - Medical Genetics Centre, Munich, Germany., Jäger D; Department of Medical Oncology, National Centre for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany., von Knebel Doeberitz M; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Haag GM; Department of Medical Oncology, National Centre for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kloor M; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany. |
| Source: | Frontiers in oncology [Front Oncol] 2021 Jun 08; Vol. 11, pp. 669774. Date of Electronic Publication: 2021 Jun 08 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34168989 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Busch+E%22">Busch E</searchLink>; Department of Medical Oncology, National Centre for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Ahadova+A%22">Ahadova A</searchLink>; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Kosmalla+K%22">Kosmalla K</searchLink>; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bohaumilitzky+L%22">Bohaumilitzky L</searchLink>; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Pfuderer+PL%22">Pfuderer PL</searchLink>; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Ballhausen+A%22">Ballhausen A</searchLink>; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Witt+J%22">Witt J</searchLink>; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wittemann+JN%22">Wittemann JN</searchLink>; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bläker+H%22">Bläker H</searchLink>; Institute of Pathology, University Hospital Leipzig, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Holinski-Feder+E%22">Holinski-Feder E</searchLink>; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.; MGZ - Medical Genetics Centre, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Jäger+D%22">Jäger D</searchLink>; Department of Medical Oncology, National Centre for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22von+Knebel+Doeberitz+M%22">von Knebel Doeberitz M</searchLink>; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Haag+GM%22">Haag GM</searchLink>; Department of Medical Oncology, National Centre for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Kloor+M%22">Kloor M</searchLink>; Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2021 Jun 08; Vol. 11, pp. 669774. <i>Date of Electronic Publication: </i>2021 Jun 08 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34168989 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2021.669774 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 669774 Titles: – TitleFull: Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Busch E – PersonEntity: Name: NameFull: Ahadova A – PersonEntity: Name: NameFull: Kosmalla K – PersonEntity: Name: NameFull: Bohaumilitzky L – PersonEntity: Name: NameFull: Pfuderer PL – PersonEntity: Name: NameFull: Ballhausen A – PersonEntity: Name: NameFull: Witt J – PersonEntity: Name: NameFull: Wittemann JN – PersonEntity: Name: NameFull: Bläker H – PersonEntity: Name: NameFull: Holinski-Feder E – PersonEntity: Name: NameFull: Jäger D – PersonEntity: Name: NameFull: von Knebel Doeberitz M – PersonEntity: Name: NameFull: Haag GM – PersonEntity: Name: NameFull: Kloor M IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 06 Text: 2021 Jun 08 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 11 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
